Relmada Therapeutics, Inc.
RLMD
$0.39
-$0.0083-2.08%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -53.38% | -49.07% | -40.57% | -36.87% | -35.06% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -25.20% | -44.08% | -84.53% | -75.65% | -70.63% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -53.03% | -48.94% | -41.83% | -37.75% | -36.21% |
|
|||||
Total Current Assets | -53.03% | -48.94% | -41.83% | -37.75% | -36.21% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -48.96% | -53.88% | 54.91% | 23.50% | 23.50% |
Total Assets | -53.03% | -48.95% | -41.80% | -37.74% | -36.20% |
|
|||||
Total Accounts Payable | 17.82% | -17.90% | -13.99% | 17.35% | -33.37% |
Total Accrued Expenses | -29.09% | 3.16% | -8.32% | 26.38% | 20.56% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -15.61% | -3.98% | -10.89% | 22.43% | -2.20% |
|
|||||
Total Current Liabilities | -15.61% | -3.98% | -10.89% | 22.43% | -2.20% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -15.57% | -3.83% | -10.89% | 22.43% | -2.20% |
|
|||||
Common Stock & APIC | 4.66% | 5.25% | 5.91% | 6.66% | 7.25% |
Retained Earnings | -14.26% | -16.14% | -16.89% | -19.31% | -21.38% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -58.38% | -52.72% | -44.77% | -42.58% | -39.22% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -58.38% | -52.72% | -44.77% | -42.58% | -39.22% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -58.38% | -52.72% | -44.77% | -42.58% | -39.22% |
|